Autonomous Therapeutics Email Format

Biotechnology ResearchMaryland, United States11-50 Employees

Autonomous Therapeutics is a biotechnology research company based in Rockville, Maryland, founded in 2017 by a team from Harvard Medical School and UCSF. It is developing therapies that are activated exclusively within diseased cells, aiming to treat a range of conditions from infectious diseases like influenza to metastatic cancers while minimizing effects on healthy tissue. The core concept relies on precision nucleic acids that detect disease signals and trigger therapeutic action only in those cells. 

Positioned in the biotechnology sector, the company focuses on improving selectivity and resistance profiles relative to conventional therapies, particularly in oncology and infectious disease contexts. In late 2024, Autonomous Therapeutics announced a collaboration with MiNK Therapeutics to pursue therapies targeting metastatic tumors.

Get verified Autonomous Therapeutics emails free

Company overview Employee directory